Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential

TSX:EDT - Post by User

Spectral Medical Inc > enrollment

<< Previous

Bullboard Posts

Next >>

Comment by BayStreetWildon Jan 25, 2023 5:46pm

118 Views

Post# 35246506

RE:RE:RE:RE:enrollment

if the company (a company that is unusually "optimistic" and it never works out) that speaks to the FDA... specifically states through its cheif medical officer that it will not end early... You can run stats until the cows come home but.... it's probably not ending early. But you do you and shill what you like.

mercedesman wrote:
BSW

I'm not the only one.

I do my research.

Also consider stats ( I know, prolly not your strong suit)

if 170 AB >= 10%

if the next 90 AB +/-/> 30%

Do the math on whether 170+ 90 "confirms" > 10% on 170+ 150 even if the last 60 (of which 20 are control) all die.

Jus sayin

MM